Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,615Revenue $M1,054Net Margin (%)5.6Z-Score2.9
Enterprise Value $M6,652EPS $-0.3Operating Margin %10.5F-Score5
P/E(ttm))91.0Cash Flow Per Share $2.2Pre-tax Margin (%)5.7Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %0Quick Ratio3.3Cash flow > EarningsY
Price/Sales5.25-y EBITDA Growth Rate %-24.1Current Ratio3.5Lower Leverage y-yY
Price/Cash Flow18.6y-y EBITDA Growth Rate %115ROA % (ttm)2.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M75.7ROI % (ttm)5.6Gross Margin Increase y-yN

Gurus Latest Trades with CBST

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CBSTVanguard Health Care Fund 2014-09-30 Add0.09%$60.5 - $70.58
($65.63)
$ 73.612%Add 34.74%1,977,342
CBSTKen Fisher 2014-06-30 Buy 0.01%$61.66 - $74.27
($67.99)
$ 73.68%New holding, 36450 sh.36,450
CBSTLee Ainslie 2014-06-30 Sold Out -1.8%$61.66 - $74.27
($67.99)
$ 73.68%Sold Out0
CBSTGeorge Soros 2014-06-30 Sold Out -0.04%$61.66 - $74.27
($67.99)
$ 73.68%Sold Out0
CBSTLee Ainslie 2014-03-31 Buy 1.8%$67.2 - $81.23
($74.39)
$ 73.6-1%New holding, 1739818 sh.1,739,818
CBSTAndreas Halvorsen 2014-03-31 Sold Out -0.24%$67.2 - $81.23
($74.39)
$ 73.6-1%Sold Out0
CBSTGeorge Soros 2014-03-31 Reduce-0.06%$67.2 - $81.23
($74.39)
$ 73.6-1%Reduce -65.4%50,000
CBSTAndreas Halvorsen 2013-12-31 Add0.05%$61.59 - $70.76
($64.66)
$ 73.614%Add 24.72%741,700
CBSTJohn Burbank 2013-12-31 Sold Out -0.42%$61.59 - $70.76
($64.66)
$ 73.614%Sold Out0
CBSTJoel Greenblatt 2013-12-31 Sold Out -0.05%$61.59 - $70.76
($64.66)
$ 73.614%Sold Out0
CBSTJohn Burbank 2013-09-30 Buy 0.42%$51.58 - $66.54
($60.56)
$ 73.622%New holding, 202451 sh.202,451
CBSTAndreas Halvorsen 2013-09-30 Buy 0.21%$51.58 - $66.54
($60.56)
$ 73.622%New holding, 594704 sh.594,704
CBSTMichael Price 2013-09-30 Sold Out -1.2%$51.58 - $66.54
($60.56)
$ 73.622%Sold Out0
CBSTGeorge Soros 2013-06-30 Buy 0.09%$44.66 - $56.11
($49.15)
$ 73.650%New holding, 175000 sh.175,000
CBSTJohn Hussman 2013-03-31 Sold Out -0.75%$40.78 - $48.06
($44.18)
$ 73.667%Sold Out0
CBSTJoel Greenblatt 2013-03-31 Reduce-0.18%$40.78 - $48.06
($44.18)
$ 73.667%Reduce -72.24%28,134
CBSTJoel Greenblatt 2012-12-31 Buy 0.25%$39.17 - $48.63
($43.07)
$ 73.671%New holding, 101334 sh.101,334
CBSTJoel Greenblatt 2012-09-30 Sold Out -0.12%$37.91 - $49.83
($43.89)
$ 73.668%Sold Out0
CBSTJoel Greenblatt 2012-06-30 Add0.04%$38.38 - $44.07
($40.88)
$ 73.680%Add 49.02%41,492
CBSTJohn Hussman 2012-03-31 Add0.18%$38.77 - $44.72
($38.64)
$ 73.690%Add 47.16%674,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CBST is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CBST Vanguard Health Care Fund 2014-09-301,977,3422.610.33+34.74%
CBST Ken Fisher 2014-09-3034,7750.050-4.6%
Premium Most recent portfolio changes are included for Premium Members only!


CBST: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-10-01Sell48,125$65.3912.56view
STEA GREGORYSVP, Commercial Operations 2014-08-19Sell38,326$65.8811.72view
TOMSICEK MICHAEL JOHNSVP & CFO 2014-08-18Sell409$63.6815.58view
PEREZ ROBERT JPresident & COO 2014-08-18Sell1,003$63.6815.58view
Hutson Nancy JDirector 2014-08-18Sell9,000$6513.23view
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-07-28Sell40,625$61.5719.54view
PEREZ ROBERT JPresident & COO 2014-05-15Sell1,518$67.59.04view
STEA GREGORYSVP, Commercial Operations 2014-05-15Sell875$67.59.04view
GILMAN STEVEN CEVP & Chief Scientific Officer 2014-05-15Sell16,340$67.828.52view
BONNEY MICHAEL WCEO 2014-05-15Sell3,036$67.59.04view

Press Releases about CBST :

    Quarterly/Annual Reports about CBST:

    News about CBST:

    Articles On GuruFocus.com
    Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
    Michael Price’s Top Sells – 11 Gurus Exit SFD Nov 19 2013 
    Magic Formula Formulator Joel Greenblatt’s Top 5 New Stock Picks Feb 14 2013 
    5 Healthcare Stocks to Consider in 2012 Mar 21 2012 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    Cubist Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
    Weekly CEO Sells Highlight: Saba Software Inc, Cubist Pharmaceuticals Inc, Polo Ralph Lauren Corp, P Apr 25 2010 
    Cubist Pharmaceuticals Inc. (CBST) President and CEO Michael W Bonney sells 184,548 Shares Apr 23 2010 
    Cubist Pharmaceuticals: A Drug Stock With Potential For Solid Gain Feb 15 2010 

    More From Our Partners
    Is This Superbug Drug Company Right for Your Portfolio? Nov 19 2014 - FOXBUSINESS

    More From Other Websites
    Is This Superbug Drug Company Right for Your Portfolio? Nov 19 2014
    European Antibiotic Awareness Day Highlights Need for Urgent Action Nov 17 2014
    European Antibiotic Awareness Day Highlights Need for Urgent Action Nov 17 2014
    European Antibiotic Awareness Day Highlights Need for Urgent Action Nov 17 2014
    CUBIST PHARMACEUTICALS INC Financials Nov 14 2014
    10-Q for Cubist Pharmaceuticals, Inc. Nov 10 2014
    CUBIST PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 07 2014
    CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits Nov 06 2014
    Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy Nov 05 2014
    Cubist Names Dr. Patrick Vink Chief Operating Officer Nov 05 2014
    Cubist Names Dr. Patrick Vink Chief Operating Officer Nov 05 2014
    Wedbush Initiates Coverage On Cubist Pharmaceuticals Nov 04 2014
    Cubist to Present at Jefferies 2014 Healthcare Conference Nov 03 2014
    Cubist to Present at Jefferies 2014 Healthcare Conference Nov 03 2014
    Cubist to Present at Jefferies 2014 Healthcare Conference Nov 03 2014
    Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen Oct 29 2014
    Cubist Pharmaceuticals' Q3 Earnings Beat Expectations Oct 23 2014
    Today's Market Thorns, Roses, and All Time Highs... Oct 22 2014
    CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits Oct 22 2014
    Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock Oct 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK